Latest On VBI Vaccines Inc (VBIV):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-15 16:15 EST | News | VBI Vaccines GAAP EPS of -$3.22, revenue of $0.49M | N/A |  |
| 2023-04-04 22:00 EST | News | VBI Vaccines falls 40% on portfolio reorganization, reverse stock split | N/A | |
| 2023-03-13 20:20 EST | News | VBI Vaccines reports FY results | N/A | |
| 2022-12-08 15:37 EST | News | VBI Vaccines wins Health Canada approval for hepatitis B vaccine PreHevbrio | N/A | |
| 2022-11-11 00:49 EST | News | VBI Vaccines GAAP EPS of -$0.10 misses by $0.02, revenue of $0.32M misses by $0.97M | N/A | |
| 2022-10-12 11:23 EST | News | VBI Vaccines, Agenus to examine VBI-1901 + balstilimab combo for glioblastoma | N/A | |
| 2022-09-23 00:55 EST | News | VBI Vaccines: Recent Updates Have Fortified My Long-Term Outlook | N/A | |
| 2022-09-15 23:49 EST | News | VBI Vaccines gets up to $100M debt funding from K2 HealthVentures | N/A | |
| 2022-09-08 19:05 EST | News | Valneva, VBI Vaccines in pact to launch Hep B vaccine in Europe | N/A | |
| 2022-08-27 04:18 EST | News | VBI Vaccines down 10% on $300M mixed shelf offering; also ends two equity offerings | N/A | |
| 2022-08-08 10:29 EST | News | VBI Vaccines Non-GAAP EPS of -$0.09 misses by $0.02, revenue of $0.35M misses by $0.35M | N/A | |
| 2022-08-08 10:29 EST | News | VBI Vaccines stock slumps 10% on Q2 miss, net loss widens on forex impact | N/A | |
| 2022-06-28 12:04 EST | News | VBI Vaccines boasts of new follow-up data for hepatitis B vaccine over GSK rival | N/A | |
| 2022-06-23 03:25 EST | News | VBI outlines next steps for brain cancer vaccine candidate after orphan drug designation | N/A | |
| 2022-06-17 20:57 EST | News | VBI Vaccines: Recent VBI-1901 Data Supports My Bull Thesis | N/A | |
| 2022-06-17 20:57 EST | News | VBI Vaccines, Hepion win FDA orphan drug designations for cancer candidates | N/A | |
| 2022-06-07 03:37 EST | News | VBI Vaccines updated phase 2 glioblastoma data shows continued overall survival benefit | N/A | |
| 2022-06-01 22:25 EST | News | VBI Vaccines hepatitis B shot PreHevbri gets approval in UK | N/A | |
| 2022-05-09 18:29 EST | News | VBI Vaccines GAAP EPS of -$0.08 in-line, revenue of $0.13M beats by $0.04M | N/A | |
| 2022-05-02 10:26 EST | News | VBI Vaccines stock rises as hepatitis B shot PreHevbri gets approval in EU | N/A | |
| 2022-03-29 14:22 EST | News | VBI Vaccines launches Hepatitis B vaccine in U.S. | N/A | |
| 2022-03-07 10:16 EST | News | VBI Vaccines GAAP EPS of $0.27 beats by $0.54, revenue of $0.63M misses by $0.17M | N/A | |
| 2022-02-25 16:07 EST | News | VBI Vaccines wins European recommendation for Hep B vaccine | N/A | |
| 2022-02-24 03:34 EST | News | VBI Vaccines wins CDC recommendation for Hep B vaccine | N/A | |
| 2021-12-30 03:13 EST | News | VBI Vaccines a buy at Jefferies on vaccine technology platform; sees 171% upside | N/A | |
| 2021-12-09 09:52 EST | News | VBI Vaccines files new drug submission for 3-antigen hepatitis B vaccine in Canada | N/A | |
| 2021-12-01 11:02 EST | News | VBI Vaccines wins FDA approval for Hepatitis B vaccine | N/A | |
| 2021-11-08 20:54 EST | News | VBI Vaccines EPS beats by $0.01, misses on revenue | N/A | |
| 2021-10-31 13:10 EST | News | VBI Vaccines: Hepatitis Vaccine Approval Can Be A Catalyst For >$1bn Valuation | N/A | |
| 2021-10-13 10:08 EST | News | VBI Vaccines reports Phase 3 data from prophylactic 3-antigen HBV vaccine study in medical journal | N/A | |
| 2021-09-30 01:37 EST | News | VBI Vaccines kicks off Phase 1b study of VBI-2905, reports preclinical data in Covid variants | N/A | |
| 2021-09-04 00:35 EST | News | VBI Vaccines dips after filing for $125M at-the-market offering | N/A | |
| 2021-08-03 20:37 EST | News | VBI Vaccines net loss widens amid pre-commercialization activities for Hep B vaccine | N/A | |
| 2021-08-03 01:41 EST | News | VBI Vaccines EPS misses by $0.01, misses on revenue | N/A | |
| 2021-07-22 07:04 EST | News | VBI Vaccines shares rise after FDA grants VBI-1901 'fast track' status | N/A | |
| 2021-07-22 06:47 EST | News | VBI Vaccines present positive VBI-2601 data in chronic hepatitis B at EASL 2021 | N/A | |
| 2021-07-22 06:41 EST | News | VBI Vaccines shares rise on data from early-stage COVID-19 vaccine study | N/A | |
| 2021-07-22 06:24 EST | News | VBI Vaccines: Turning My Focus To VBI-1901 | N/A | |
| 2021-04-29 00:24 EST | News | VBI Vaccines reports preclinical VBI-2902 data in COVID-19 | N/A | |
| 2021-04-29 00:23 EST | News | VBI Vaccines: Reloading My Position Ahead Of Transformative Catalysts | N/A | |
| 2021-04-13 03:41 EST | News | VBI’s hepatitis B candidate shows robust response in Phase 1/2 study | N/A | |
| 2021-03-10 21:01 EST | News | VBI Vaccine shares gain on CEPI collab to advance vaccine against COVID-19 variants | N/A | |
| 2021-03-10 01:28 EST | News | VBI Vaccines shares rise on enrollment in study of COVID-19 vaccine candidate, VBI-2902 | N/A | |
| 2021-03-03 20:58 EST | Financials | Company financials have been released. | Neutral | |
| 2021-03-03 12:39 EST | Earnings Estimate | An EPS average of -$0.10 is estimated for the 2022 year. | Sell | |
| 2021-03-03 12:39 EST | Earnings Estimate | An EPS average of -$0.07 is estimated for the quarter ending on June 30, 2021. | Sell | |
| 2021-03-02 21:09 EST | News | VBI Vaccines EPS misses by $0.15, misses on revenue | N/A | |
| 2021-02-26 16:32 EST | Analyst Rating | The Analyst Target Price has increased from $6.5 to $6.6. | Buy | |
| 2021-02-18 23:57 EST | News | COVID-19 vaccine developers to benefit from supply constraints and uneven distribution | N/A | |
| 2021-02-10 20:33 EST | News | VBI shares turn higher following talk of 'pancoronavirus' vaccine | N/A | |
About VBI Vaccines Inc (VBIV):
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The company's enveloped virus-like particle (eVLP) platform technology allows for the development of eVLP vaccines that mimic the presentation of viruses to elicit a human immune system. Its lead eVLP program candidates include VBI-1901, a glioblastoma vaccine immunotherapeutic candidate, which is in Phase I/IIa clinical study; and VBI-1501, a prophylactic cytomegalovirus vaccine candidate that has completed Phase I clinical trial. The company also develops coronavirus vaccine candidates, such as VBI-2902 and VBI-2901. In addition, it engages in the development of vaccine platforms and products for licensing to pharmaceutical companies and biotechnology companies. The company primarily serves physicians and pharmacists through direct sales. It has collaboration and license agreements with Brii Biosciences Limited; and GlaxoSmithKline Biologicals S.A. The company also has a collaboration with the National Research Council of Canada to develop pan-coronavirus vaccine candidate targeting COVID-19, severe acute respiratory syndrome, and Middle East respiratory syndrome. VBI Vaccines Inc. has collaboration with Coalition For Epidemic Preparedness Innovations to advance vaccine candidates against Covid-19 variants. The company was formerly known as SciVac Therapeutics Inc. and changed its name to VBI Vaccines Inc. in May 2016. VBI Vaccines Inc. is headquartered in Cambridge, Massachusetts.
General
- Name VBI Vaccines Inc
- Symbol VBIV
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 127
- Last Split Factor1:40
- Last Split Date2016-05-02
- Fiscal Year EndDecember
- IPO Date1995-08-18
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.vbivaccines.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 687.11
- Price/Book (Most Recent Quarter) 4.94
- Enterprise Value Revenue 704.21
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$0.26
- Next Year EPS Estimate -$0.11
- Next Quarter EPS Estimate -$0.06
- Operating Margin -4111%
- Return on Assets -16%
- Return on Equity -36%
- Revenue 1.06 million
- Earnings Per Share -$0.76
- Revenue Per Share $0.01
- Gross Profit -8107000
- Quarterly Earnings Growth -71.4%
View More
Highlights
- Market Capitalization 915.69 million
- EBITDA -58497000
- PE Ratio -0.13
- Analyst Target Price $6.6
- Book Value Per Share $0.70
View More
Share Statistics
- Shares Outstanding 254 million
- Shares Float 177.44 million
- % Held by Insiders 348%
- % Held by Institutions 57.81%
- Shares Short 40.82 million
- Shares Short Prior Month 39.53 million
- Short Ratio 4.5
- Short % of Float 21%
- Short % of Shares Outstanding 16%
View More
Technicals
- Beta 1.99
- 52 Week High $6.93
- 52 Week Low $0.71
- 50 Day Moving Average 3.54
- 200 Day Moving Average 3.14
View More
Dividends
- Dividend Date 2012-12-28
- ExDividend Date N/A
- Dividend Yield 0%
View More
VBI Vaccines Inc (VBIV) Dividend Calendar:
VBIV's last dividend payment was made to shareholders on December 28, 2012.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
VBI Vaccines Inc (VBIV) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-03-02 | $164000 | -$0.06 | -$0.05 | -12.57% |
| 2020-09-30 | 2020-11-02 | $298000 | -$0.06 | -$0.05 | -33.33% |
| 2020-06-30 | 2020-07-31 | $N/A | -$0.04 | -$0.04 | 0% |
| 2020-03-31 | 2020-05-06 | $415000 | -$0.05 | -$0.07 | 23.08% |
| 2019-12-31 | 2020-03-05 | $574000 | -$0.02 | -$0.06 | 65.22% |
| 2019-09-30 | 2019-11-06 | $647000 | -$0.15 | -$0.13 | -20% |
| 2019-06-30 | 2019-08-09 | $640000 | -$0.13 | -$0.14 | 7.14% |
| 2019-03-31 | 2019-05-01 | $360000 | -$0.15 | -$0.15 | 0% |
| 2018-12-31 | 2019-02-25 | $2.68 million | -$0.28 | -$0.22 | -29.21% |
| 2018-09-30 | 2018-11-09 | $259000 | -$0.24 | -$0.24 | 0% |
| 2018-06-30 | 2018-07-26 | $234000 | -$0.26 | -$0.17 | -52.94% |
| 2018-03-31 | 2018-05-01 | $178000 | -$0.19 | -$0.17 | -11.76% |
| 2017-12-31 | 2018-02-26 | $201000 | -$0.20 | -$0.20 | 0% |
| 2017-09-30 | 2017-11-13 | $193000 | -$0.24 | -$0.22 | -9.09% |
| 2017-06-30 | 2017-07-31 | $344000 | -$0.22 | -$0.21 | -6.43% |
| 2017-03-31 | 2017-05-15 | $127000 | -$0.22 | -$0.16 | -41.94% |
| 2016-12-31 | 2017-03-20 | $137000 | -$0.23 | -$0.16 | -43.75% |
| 2016-09-30 | 2016-11-09 | $281000 | -$0.20 | -$0.17 | -15.41% |
| 2016-06-30 | 2016-08-15 | $82000 | -$0.23 | -$0.19 | -21.05% |
| 2016-03-31 | 2016-05-13 | $48000 | -$0.06 | ||
| 2014-03-31 | 2014-03-31 | $498603 | -$0.32 | ||
| 2013-12-31 | 2013-12-31 | -$0.32 | |||
| 2013-09-30 | 2013-09-30 | -$0.22 | |||
| 2013-06-30 | 2013-06-30 | -$0.10 | |||
| 2013-03-31 | 2013-03-31 | -$0.09 | |||
| 2012-12-31 | 2012-12-31 | -$0.21 | |||
| 2012-09-30 | 2012-09-30 | -$0.68 | |||
| 2012-06-30 | 2012-06-30 | -$0.37 | |||
| 2012-03-31 | 2012-03-31 | -$0.62 | |||
| 2011-12-31 | 2011-12-31 | -$0.56 | |||
| 2011-09-30 | 2011-09-30 | -$0.70 | |||
| 2011-06-30 | 2011-06-30 | -$0.90 | |||
| 2011-03-31 | 2011-03-31 | -$7.23 | |||
| 2010-12-31 | 2010-12-31 | -$0.31 | |||
| 2010-09-30 | 2010-09-30 | -$1.80 | |||
| 2010-06-30 | 2010-06-30 | -$0.16 | |||
| 2010-03-31 | 2010-03-31 | -$0.26 | |||
| 2009-12-31 | 2009-12-31 | -$0.12 | |||
| 2009-09-30 | 2009-09-30 | -$0.06 | |||
| 2009-06-30 | 2009-06-30 | -$0.06 | |||
| 2008-12-31 | 2008-12-31 | -$0.05 | |||
| 2008-09-30 | 2008-09-30 | -$0.08 | |||
| 2008-06-30 | 2008-06-30 | -$0.05 | |||
| 2008-03-31 | 2008-03-31 | -$0.13 | |||
| 2007-12-31 | 2007-12-31 | -$0.15 | |||
| 2007-09-30 | 2007-09-30 | -$0.16 | |||
| 2007-06-30 | 2007-06-30 | -$0.07 | |||
| 2007-03-31 | 2007-03-31 | $0.00 | |||
| 2006-12-31 | 2006-12-31 | -$0.06 | |||
| 2006-09-30 | 2006-09-30 | -$0.10 | |||
| 2006-06-30 | 2006-06-30 | -$0.07 | |||
| 2006-03-31 | 2006-03-31 | -$0.34 | |||
| 2005-12-31 | 2005-12-31 | -$0.05 | |||
| 2005-09-30 | 2005-09-30 | -$0.07 | |||
| 2005-06-30 | 2005-06-30 | -$0.06 | |||
| 2005-03-31 | 2005-03-31 | $0.04 | |||
| 2004-12-31 | 2004-12-31 | -$0.03 | |||
| 2004-09-30 | 2004-09-30 | -$0.04 | |||
| 2004-06-30 | 2004-06-30 | -$0.04 | |||
| 2004-03-31 | 2004-03-31 | -$0.07 | |||
| 2003-12-31 | 2003-12-31 | -$0.13 | |||
| 2003-09-30 | 2003-09-30 | -$0.08 | |||
| 2003-06-30 | 2003-06-30 | -$0.08 | |||
| 2003-03-31 | 2003-03-31 | -$0.12 | |||
| 2002-12-31 | 2002-12-31 | -$0.02 | |||
| 2002-09-30 | 2002-09-30 | -$0.05 | |||
| 2002-06-30 | 2002-06-30 | -$0.03 | |||
| 2002-03-31 | 2002-03-31 | -$1.46 | |||
| 2001-12-31 | 2001-12-31 | -$0.03 | |||
| 2001-09-30 | 2001-09-30 | -$0.03 | |||
| 2001-06-30 | 2001-06-30 | -$0.05 |
VBI Vaccines Inc (VBIV) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
VBI Vaccines Inc (VBIV) Chart:
VBI Vaccines Inc (VBIV) News:
Below you will find a list of latest news for VBI Vaccines Inc (VBIV) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
VBI Vaccines Inc (VBIV) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2024-04-19 | 2.5 | 0.03 | CALL | 0 | 234 | 0 | FALSE | 0 | 0 |
| 2024-04-19 | 5 | 0.03 | CALL | 0 | 7 | 0 | FALSE | 0 | 0 |
| 2024-04-19 | 7.5 | 0.03 | CALL | 0 | 2 | 0 | FALSE | 0 | 0 |
| 2024-04-19 | 2.5 | 1.4 | PUT | 0 | 120 | 0 | TRUE | 0 | 0 |
| 2024-04-19 | 5 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-04-19 | 7.5 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-05-17 | 2.5 | 0.04 | CALL | 0 | 305 | 351.05 | FALSE | 0 | 0 |
| 2024-05-17 | 5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 7.5 | 0.05 | CALL | 0 | 7 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 2.5 | 1.95 | PUT | 0 | 1 | 782.7 | TRUE | 0 | 0 |
| 2024-05-17 | 5 | 4.38 | PUT | 0 | 0 | 808.39 | TRUE | 0 | 0 |
| 2024-05-17 | 7.5 | 6.73 | PUT | 0 | 0 | 870.24 | TRUE | 0 | 0 |
| 2024-07-19 | 2.5 | 0.05 | CALL | 0 | 12923 | 235.3 | FALSE | 0 | 0 |
| 2024-07-19 | 5 | 0.05 | CALL | 0 | 24 | 0 | FALSE | 0 | 0 |
| 2024-07-19 | 7.5 | 0.02 | CALL | 0 | 5 | 0 | FALSE | 0 | 0 |
| 2024-07-19 | 2.5 | 1.85 | PUT | 0 | 30 | 181.71 | TRUE | 0 | 0 |
| 2024-07-19 | 5 | 0 | PUT | 0 | 0 | 334.94 | TRUE | 0 | 0 |
| 2024-07-19 | 7.5 | 0 | PUT | 0 | 0 | 431.78 | TRUE | 0 | 0 |
| 2024-10-18 | 2.5 | 0.1 | CALL | 0 | 427 | 248.23 | FALSE | 0 | 0 |
| 2024-10-18 | 5 | 0.1 | CALL | 0 | 1 | 0 | FALSE | 0 | 0 |
| 2024-10-18 | 7.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-10-18 | 2.5 | 1.95 | PUT | 0 | 5 | 245.48 | TRUE | 0 | 0 |
| 2024-10-18 | 5 | 0 | PUT | 0 | 0 | 175.04 | TRUE | 0 | 0 |
| 2024-10-18 | 7.5 | 0 | PUT | 0 | 0 | 230.34 | TRUE | 0 | 0 |
Latest VBIV Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 100 | $0.6801 |
| Jun 13, 2022 7:59 PM EST | 100 | $0.6801 |
| Jun 13, 2022 7:59 PM EST | 100 | $0.6801 |
| Jun 13, 2022 7:59 PM EST | 200 | $0.6801 |
| Jun 13, 2022 7:59 PM EST | 147 | $0.6801 |
VBI Vaccines Inc (VBIV) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/764195/000149315220012556/0001493152-20-012556-index.htm |
| 2020-02-07 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/764195/000083423720008030/0000834237-20-008030-index.htm |
| 2020-06-09 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/764195/000083423720009578/0000834237-20-009578-index.htm |
| 2019-09-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/764195/000089924319024191/0000899243-19-024191-index.htm |
| 2020-04-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/764195/000089924320011371/0000899243-20-011371-index.htm |
| 2018-12-26 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/764195/000092189518003382/0000921895-18-003382-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/764195/000092189520000544/0000921895-20-000544-index.htm |
| 2019-03-13 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/764195/000094480919000019/0000944809-19-000019-index.htm |
| 2019-09-30 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/764195/000094480919000062/0000944809-19-000062-index.htm |
| 2019-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/764195/000101297519000443/0001012975-19-000443-index.htm |
| 2019-06-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/764195/000101297519000447/0001012975-19-000447-index.htm |
| 2019-10-10 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/764195/000107261319000280/0001072613-19-000280-index.htm |
| 2019-06-12 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/764195/000119312519171297/0001193125-19-171297-index.htm |
| 2019-06-20 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/764195/000119312519177548/0001193125-19-177548-index.htm |
| 2019-09-26 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/764195/000119312519256069/0001193125-19-256069-index.htm |
| 2020-04-28 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/764195/000119312520122131/0001193125-20-122131-index.htm |
| 2018-12-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315218017690/0001493152-18-017690-index.htm |
| 2018-12-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315218017749/0001493152-18-017749-index.htm |
| 2019-01-15 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/764195/000149315219000670/0001493152-19-000670-index.htm |
| 2019-01-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315219000696/0001493152-19-000696-index.htm |
| 2019-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/764195/000149315219001328/0001493152-19-001328-index.htm |
| 2019-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/764195/000149315219001331/0001493152-19-001331-index.htm |
| 2019-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/764195/000149315219001334/0001493152-19-001334-index.htm |
| 2019-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/764195/000149315219001335/0001493152-19-001335-index.htm |
| 2019-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/764195/000149315219001336/0001493152-19-001336-index.htm |
| 2019-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/764195/000149315219001337/0001493152-19-001337-index.htm |
| 2019-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/764195/000149315219001340/0001493152-19-001340-index.htm |
| 2019-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/764195/000149315219001342/0001493152-19-001342-index.htm |
| 2019-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/764195/000149315219001344/0001493152-19-001344-index.htm |
| 2019-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/764195/000149315219001346/0001493152-19-001346-index.htm |
| 2019-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/764195/000149315219001347/0001493152-19-001347-index.htm |
| 2019-02-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315219001392/0001493152-19-001392-index.htm |
| 2019-02-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315219001686/0001493152-19-001686-index.htm |
| 2019-02-25 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/764195/000149315219002481/0001493152-19-002481-index.htm |
| 2019-02-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315219002524/0001493152-19-002524-index.htm |
| 2019-03-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315219003575/0001493152-19-003575-index.htm |
| 2019-04-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315219004514/0001493152-19-004514-index.htm |
| 2019-04-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315219004841/0001493152-19-004841-index.htm |
| 2019-04-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315219005048/0001493152-19-005048-index.htm |
| 2019-04-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315219005191/0001493152-19-005191-index.htm |
| 2019-04-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315219005525/0001493152-19-005525-index.htm |
| 2019-04-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315219005829/0001493152-19-005829-index.htm |
| 2019-04-24 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/764195/000149315219005871/0001493152-19-005871-index.htm |
| 2019-04-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/764195/000149315219005873/0001493152-19-005873-index.htm |
| 2019-04-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315219005894/0001493152-19-005894-index.htm |
| 2019-04-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315219005992/0001493152-19-005992-index.htm |
| 2019-04-29 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/764195/000149315219006075/0001493152-19-006075-index.htm |
| 2019-04-29 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/764195/000149315219006076/0001493152-19-006076-index.htm |
| 2019-05-01 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/764195/000149315219006225/0001493152-19-006225-index.htm |
| 2019-05-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315219006238/0001493152-19-006238-index.htm |
| 2019-05-10 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/764195/000149315219006803/0001493152-19-006803-index.htm |
| 2019-06-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315219008650/0001493152-19-008650-index.htm |
| 2019-06-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315219009160/0001493152-19-009160-index.htm |
| 2019-06-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315219009279/0001493152-19-009279-index.htm |
| 2019-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/764195/000149315219009375/0001493152-19-009375-index.htm |
| 2019-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/764195/000149315219009377/0001493152-19-009377-index.htm |
| 2019-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/764195/000149315219009380/0001493152-19-009380-index.htm |
| 2019-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/764195/000149315219009381/0001493152-19-009381-index.htm |
| 2019-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/764195/000149315219009383/0001493152-19-009383-index.htm |
| 2019-06-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/764195/000149315219009422/0001493152-19-009422-index.htm |
| 2019-06-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/764195/000149315219009424/0001493152-19-009424-index.htm |
| 2019-06-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/764195/000149315219009492/0001493152-19-009492-index.htm |
| 2019-06-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315219009565/0001493152-19-009565-index.htm |
| 2019-07-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/764195/000149315219009942/0001493152-19-009942-index.htm |
| 2019-07-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315219011253/0001493152-19-011253-index.htm |
| 2019-08-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315219011590/0001493152-19-011590-index.htm |
| 2019-08-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315219011862/0001493152-19-011862-index.htm |
| 2019-08-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/764195/000149315219011951/0001493152-19-011951-index.htm |
| 2019-08-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315219012016/0001493152-19-012016-index.htm |
| 2019-08-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315219012859/0001493152-19-012859-index.htm |
| 2019-09-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315219013728/0001493152-19-013728-index.htm |
| 2019-09-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315219013910/0001493152-19-013910-index.htm |
| 2019-09-18 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/764195/000149315219014263/0001493152-19-014263-index.htm |
| 2019-09-20 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/764195/000149315219014391/0001493152-19-014391-index.htm |
| 2019-09-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315219014392/0001493152-19-014392-index.htm |
| 2019-09-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315219014583/0001493152-19-014583-index.htm |
| 2019-09-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/764195/000149315219014759/0001493152-19-014759-index.htm |
| 2019-10-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/764195/000149315219014801/0001493152-19-014801-index.htm |
| 2019-10-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/764195/000149315219014802/0001493152-19-014802-index.htm |
| 2019-10-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315219014865/0001493152-19-014865-index.htm |
| 2019-10-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/764195/000149315219015126/0001493152-19-015126-index.htm |
| 2019-10-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315219015848/0001493152-19-015848-index.htm |
| 2019-10-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315219015917/0001493152-19-015917-index.htm |
| 2019-11-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/764195/000149315219016516/0001493152-19-016516-index.htm |
| 2019-11-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315219016518/0001493152-19-016518-index.htm |
| 2019-11-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315219016781/0001493152-19-016781-index.htm |
| 2019-11-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315219017546/0001493152-19-017546-index.htm |
| 2019-11-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315219018204/0001493152-19-018204-index.htm |
| 2020-01-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315220000447/0001493152-20-000447-index.htm |
| 2020-01-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315220000595/0001493152-20-000595-index.htm |
| 2020-01-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/764195/000149315220001067/0001493152-20-001067-index.htm |
| 2020-01-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/764195/000149315220001071/0001493152-20-001071-index.htm |
| 2020-01-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/764195/000149315220001072/0001493152-20-001072-index.htm |
| 2020-01-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/764195/000149315220001078/0001493152-20-001078-index.htm |
| 2020-01-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/764195/000149315220001079/0001493152-20-001079-index.htm |
| 2020-01-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/764195/000149315220001087/0001493152-20-001087-index.htm |
| 2020-01-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/764195/000149315220001088/0001493152-20-001088-index.htm |
| 2020-01-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/764195/000149315220001089/0001493152-20-001089-index.htm |
| 2020-01-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/764195/000149315220001090/0001493152-20-001090-index.htm |
| 2020-01-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/764195/000149315220001092/0001493152-20-001092-index.htm |
| 2020-03-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315220003194/0001493152-20-003194-index.htm |
| 2020-03-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315220003250/0001493152-20-003250-index.htm |
| 2020-03-05 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/764195/000149315220003413/0001493152-20-003413-index.htm |
| 2020-03-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315220003421/0001493152-20-003421-index.htm |
| 2020-03-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315220003866/0001493152-20-003866-index.htm |
| 2020-03-16 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/764195/000149315220004039/0001493152-20-004039-index.htm |
| 2020-03-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/764195/000149315220004653/0001493152-20-004653-index.htm |
| 2020-03-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315220005406/0001493152-20-005406-index.htm |
| 2020-04-21 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/764195/000149315220006841/0001493152-20-006841-index.htm |
| 2020-04-24 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/764195/000149315220007010/0001493152-20-007010-index.htm |
| 2020-04-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315220007012/0001493152-20-007012-index.htm |
| 2020-04-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315220007113/0001493152-20-007113-index.htm |
| 2020-04-28 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/764195/000149315220007261/0001493152-20-007261-index.htm |
| 2020-04-28 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/764195/000149315220007264/0001493152-20-007264-index.htm |
| 2020-05-01 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/764195/000149315220007484/0001493152-20-007484-index.htm |
| 2020-05-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/764195/000149315220007781/0001493152-20-007781-index.htm |
| 2020-05-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315220007783/0001493152-20-007783-index.htm |
| 2020-05-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315220008986/0001493152-20-008986-index.htm |
| 2020-05-27 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/764195/000149315220009917/0001493152-20-009917-index.htm |
| 2020-05-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315220009938/0001493152-20-009938-index.htm |
| 2020-05-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315220010122/0001493152-20-010122-index.htm |
| 2020-06-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315220011319/0001493152-20-011319-index.htm |
| 2020-06-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315220011562/0001493152-20-011562-index.htm |
| 2020-06-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315220011569/0001493152-20-011569-index.htm |
| 2020-07-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315220012545/0001493152-20-012545-index.htm |
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/764195/000149315220012548/0001493152-20-012548-index.htm |
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/764195/000149315220012550/0001493152-20-012550-index.htm |
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/764195/000149315220012552/0001493152-20-012552-index.htm |
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/764195/000149315220012553/0001493152-20-012553-index.htm |
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/764195/000149315220012555/0001493152-20-012555-index.htm |
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/764195/000149315220012556/0001493152-20-012556-index.htm |
| 2020-07-31 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/764195/000149315220014278/0001493152-20-014278-index.htm |
| 2020-07-31 | S-3ASR | Automatic shelf registration statement of securities of well-known seasoned issuers | https://www.sec.gov/Archives/edgar/data/764195/000149315220014355/0001493152-20-014355-index.htm |
| 2020-07-31 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/764195/000149315220014358/0001493152-20-014358-index.htm |
| 2020-08-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315220014448/0001493152-20-014448-index.htm |
| 2020-08-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315220014680/0001493152-20-014680-index.htm |
| 2020-08-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315220016492/0001493152-20-016492-index.htm |
| 2020-08-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315220016722/0001493152-20-016722-index.htm |
| 2020-08-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315220016973/0001493152-20-016973-index.htm |
| 2020-09-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315220017703/0001493152-20-017703-index.htm |
| 2020-09-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315220017960/0001493152-20-017960-index.htm |
| 2020-09-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315220018052/0001493152-20-018052-index.htm |
| 2020-09-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315220018256/0001493152-20-018256-index.htm |
| 2020-10-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315220019193/0001493152-20-019193-index.htm |
| 2020-10-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315220019471/0001493152-20-019471-index.htm |
| 2020-10-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315220019917/0001493152-20-019917-index.htm |
| 2020-11-02 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/764195/000149315220020276/0001493152-20-020276-index.htm |
| 2020-11-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/764195/000149315220020291/0001493152-20-020291-index.htm |
| 2019-03-11 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/764195/999999999719000921/9999999997-19-000921-index.htm |
VBI Vaccines Inc (VBIV) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of VBI Vaccines Inc (VBIV). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 348%Institutional Ownership: 5781%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2019-10-04 | Francisco Diaz-Mitoma | Chief Medical Officer | Buy | 40,000.00 | 0.50 | 20,000.00 | 117,500.00 | https://www.sec.gov/Archives/edgar/data/764195/000149315219015126/0001493152-19-015126-index.htm |
| 2019-01-31 | David Evander Anderson | Chief Scientific Officer | Buy | 25,000.00 | 126,334.00 | https://www.sec.gov/Archives/edgar/data/764195/000149315219001331/0001493152-19-001331-index.htm | ||
| 2019-09-30 | Francisco Diaz-Mitoma | Chief Medical Officer | Buy | 14,500.00 | 0.50 | 7,250.00 | 14,500.00 | https://www.sec.gov/Archives/edgar/data/764195/000149315219015126/0001493152-19-015126-index.htm |
| 2019-06-14 | David Evander Anderson | Chief Scientific Officer | Buy | 21,875.00 | 148,209.00 | https://www.sec.gov/Archives/edgar/data/764195/000149315219009380/0001493152-19-009380-index.htm | ||
| 2019-01-31 | Avi Mazaltov | Head Global MFG&GM-SciVac Ltd. | Buy | 90,000.00 | 196,000.00 | https://www.sec.gov/Archives/edgar/data/764195/000149315219001334/0001493152-19-001334-index.htm | ||
| 2019-06-17 | PERCEPTIVE ADVISORS LLC | 10% Share Holder | Buy | 1,000,000.00 | 0.62 | 618,000.00 | 24,951,556.00 | https://www.sec.gov/Archives/edgar/data/764195/000101297519000443/0001012975-19-000443-index.htm |
| 2019-01-31 | Christopher McNulty | CFO and Head of BD | Buy | 25,000.00 | 25,000.00 | https://www.sec.gov/Archives/edgar/data/764195/000149315219001336/0001493152-19-001336-index.htm | ||
| 2019-06-18 | PERCEPTIVE ADVISORS LLC | 10% Share Holder | Buy | 1,000,000.00 | 0.65 | 650,000.00 | 25,951,556.00 | https://www.sec.gov/Archives/edgar/data/764195/000101297519000447/0001012975-19-000447-index.htm |
| 2019-06-20 | Francisco Diaz-Mitoma | Chief Medical Officer | Buy | 10,000.00 | 0.78 | 7,800.00 | 27,500.00 | https://www.sec.gov/Archives/edgar/data/764195/000149315219009492/0001493152-19-009492-index.htm |
| 2019-01-31 | Jeff Baxter | CEO, President | Buy | 50,000.00 | 283,005.00 | https://www.sec.gov/Archives/edgar/data/764195/000149315219001340/0001493152-19-001340-index.htm | ||
| 2019-06-14 | Jeff Baxter | CEO, President | Buy | 31,250.00 | 314,255.00 | https://www.sec.gov/Archives/edgar/data/764195/000149315219009383/0001493152-19-009383-index.htm | ||
| 2019-01-31 | Nell Beattie | Chief Business Officer | Buy | 15,000.00 | 35,750.00 | https://www.sec.gov/Archives/edgar/data/764195/000149315219001328/0001493152-19-001328-index.htm | ||
| 2019-10-01 | Christopher McNulty | CFO and Head of BD | Buy | 12,000.00 | 0.47 | 5,676.00 | 37,000.00 | https://www.sec.gov/Archives/edgar/data/764195/000149315219014802/0001493152-19-014802-index.htm |
| 2019-06-14 | Nell Beattie | Chief Business Officer | Buy | 6,250.00 | 42,000.00 | https://www.sec.gov/Archives/edgar/data/764195/000149315219009375/0001493152-19-009375-index.htm | ||
| 2019-06-19 | Jeff Baxter | CEO, President | Buy | 144,000.00 | 0.73 | 105,336.00 | 458,255.00 | https://www.sec.gov/Archives/edgar/data/764195/000149315219009422/0001493152-19-009422-index.htm |
| 2019-09-23 | PERCEPTIVE ADVISORS LLC | 10% Share Holder | Buy | 20,000,000.00 | 0.50 | 10,000,000.00 | 45,951,556.00 | https://www.sec.gov/Archives/edgar/data/764195/000089924319024191/0000899243-19-024191-index.htm |
| 2019-06-14 | Michel DeWilde | Director | Buy | 12,500.00 | 50,000.00 | https://www.sec.gov/Archives/edgar/data/764195/000149315219009377/0001493152-19-009377-index.htm | ||
| 2019-06-19 | Nell Beattie | Chief Business Officer | Buy | 8,000.00 | 0.74 | 5,885.60 | 50,000.00 | https://www.sec.gov/Archives/edgar/data/764195/000149315219009424/0001493152-19-009424-index.htm |
| 2020-04-24 | PERCEPTIVE ADVISORS LLC | 10% Share Holder | Buy | 9,090,909.00 | 1.10 | 9,999,999.90 | 55,042,456.00 | https://www.sec.gov/Archives/edgar/data/764195/000089924320011371/0000899243-20-011371-index.htm |
| 2019-10-01 | Nell Beattie | Chief Business Officer | Buy | 10,000.00 | 0.48 | 4,822.00 | 60,000.00 | https://www.sec.gov/Archives/edgar/data/764195/000149315219014801/0001493152-19-014801-index.htm |
| 2019-09-30 | Jeff Baxter | CEO, President | Buy | 150,000.00 | 0.50 | 75,450.00 | 608,255.00 | https://www.sec.gov/Archives/edgar/data/764195/000149315219014759/0001493152-19-014759-index.htm |
| 2019-06-20 | Francisco Diaz-Mitoma | Chief Medical Officer | Buy | 42,000.00 | 0.89 | 37,380.00 | 69,500.00 | https://www.sec.gov/Archives/edgar/data/764195/000149315219009492/0001493152-19-009492-index.htm |
| 2019-06-27 | Francisco Diaz-Mitoma | Chief Medical Officer | Buy | 8,000.00 | 1.07 | 8,560.00 | 77,500.00 | https://www.sec.gov/Archives/edgar/data/764195/000149315219009942/0001493152-19-009942-index.htm |
| 2019-06-14 | STEVEN GILLIS | Director | Buy | 18,750.00 | 84,416.00 | https://www.sec.gov/Archives/edgar/data/764195/000149315219009381/0001493152-19-009381-index.htm |